Layer 1
Editors Comment

Refine

E.g., 08/07/2020
E.g., 08/07/2020

Refine

Refine

E.g., 08/07/2020
E.g., 08/07/2020

editors comment

When I finished my first week as a freelance reporter at C+D back in 2011, I couldn’t have known I would have the privilege of one day leading the...
24/01/2020 3
Whether it was the implementation of the Falsified Medicines Directive, unannounced inspections or the five-year funding contract in England, 2019...
03/01/2020 3
Lloydspharmacy’s “difficult” decision to charge patients for diabetes screening and blood pressure checks this week won’t come as a surprise to many...
24/05/2019 5
In a number of conversations with pharmacy owners in England over the past six months, I’ve had a similar experience. We may start the conversation...
19/03/2019 0
It would be unfair to say we weren’t warned. Pharmaceutical Services Negotiating Committee (PSNC) CEO Simon Dukes and director of funding Mike Dent...
22/10/2018 5
What’s in a name? Quite a lot, judging by the outrage of some community pharmacists when they see the phrase “clinical pharmacist” being used to...
18/10/2018 8
“These terms have a corroding effect on political discourse”
What’s in a name? Quite a lot, judging by the outrage of some community pharmacists when they see the phrase “clinical pharmacist” being used to...
19/09/2018 0
So the final skirmish of the 18-month funding cuts court battle has ended. The casualties include the credibility of the government’s decision-making...
23/08/2018 0
“Investment in community pharmacies.” Four small words that would have huge significance for the sector in England – if they ever become a reality....
07/08/2018 5
“We need primary legislation to change the sluggish pharmacy contract.” It’s the kind of statement you’d expect to originate from an exasperated...
25/05/2018 0

Pages